Collegium Pharmaceutical, Inc. is a privately held, venture backed, commercial stage, specialty pharmaceutical company focused on late-stage development, and commercialization of prescription pharmaceuticals for the treatment of central nervous system ("CNS"), respiratory and skin related disorders. The Company, through its wholly-owned subsidiary, Onset Therapeutics LLC (www.onsettx.com) markets innovative proprietary therapies to the wound care and dermatology markets. Onset currently markets six prescription pharmaceutical products through its field and in-house sales force.